SAM
CRBU icon

Stansberry Asset Management’s Caribou Biosciences CRBU Stock Holding History

Stansberry Asset Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-29,969
Closed -$49.1K – 127
2024
Q2 		$49.1K Sell
29,969
-34,368
-53% -$110K 0.01% 127
2024
Q1 		$331K Sell
64,337
-4,113
-6% -$25.4K 0.04% 114
2023
Q4 		$392K Sell
68,450
-8,782
-11% -$43.4K 0.07% 104
2023
Q3 		$369K Buy
77,232
+5,737
+8% +$35.6K 0.06% 103
2023
Q2 		$304K Buy
71,495
+638
+0.9% +$2.87K 0.06% 92
2023
Q1 		$376K Buy
70,857
+853
+1% +$5.31K 0.07% 93
2022
Q4 		$440K Buy
70,004
+2,342
+3% +$20.8K 0.09% 91
2022
Q3 		$714K Sell
67,662
-1,676
-2% -$15.6K 0.15% 84
2022
Q2 		$376K Sell
69,338
-23,451
-25% -$179K 0.08% 96
2022
Q1 		$852K Buy
92,789
+25,418
+38% +$268K 0.14% 91
2021
Q4 		$1.02M Buy
67,371
+40,047
+147% +$779K 0.16% 68
2021
Q3 		$652K Buy
+27,324
New +$668K 0.13% 62

Other funds holding CRBU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Stansberry Asset Management's CRBU Position: Q3 2024 in Review

Stansberry Asset Management sold out of Caribou Biosciences (CRBU) in Q3 2024, closing a stake of 29,969 shares — an estimated $49.1K sold.

Stansberry Asset Management first reported a position in CRBU in Q3 2021 and held it in 12 quarters. The position peaked at $1.02M in Q4 2021. 129 funds tracked by Wall St. Rank hold CRBU as of Q3 2024.

  • Stansberry Asset Management reported no remaining Caribou Biosciences position as of Q3 2024 after selling out during the quarter.
  • Stansberry Asset Management sold 29,969 Caribou Biosciences shares in Q3 2024, an estimated $49.1K.
  • Stansberry Asset Management first reported a position in Caribou Biosciences in Q3 2021 and held it in 12 quarters.
  • Stansberry Asset Management's Caribou Biosciences position peaked at $1.02M in Q4 2021.
  • 129 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2024.

Based on Stansberry Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.